RGT anti-a bcln 150ML mncln ABO GRP BB
Ended Awarded Last action
- Contract number
- SPE2D626F867X
- Awardee
-
Ortho-Clinical Diagnostics, Inc. UEI JG5JF2JQJ121
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,716
Award facts
- Contract value 100% obligated
- $2,716.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
On December 5, 2025, the Defense Health Agency's Medical Supply Chain awarded a $2,716.20 fixed-price delivery order with economic price adjustment to Ortho-Clinical Diagnostics, Inc. (UEI: JG5JF2JQJ121) for 150 milliliters of Reagent Anti-A Bioclone blood bank reagent with ABO grouping capability. The contract, which carries an ultimate completion date of March 2, 2026, was awarded without set-aside designation through open competition. Performance will be executed at the contractor's headquarters in Raritan, New Jersey. This delivery order is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule, enabling streamlined procurement of specialized laboratory diagnostic supplies across federal healthcare entities.
Ortho-Clinical Diagnostics, Inc. is a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey, specializing in advanced diagnostic solutions for federal healthcare agencies. The company maintains an extensive portfolio of federal contracts across multiple agencies including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and National Institutes of Health, with several active indefinite delivery contracts and blanket purchase agreements valued in the millions of dollars. The company's primary offerings include blood bank reagents and analyzers, transfusion analyzer supplies, chemistry testing services, immunochemistry products, and related laboratory equipment and maintenance services, positioning it as a critical supplier of blood banking diagnostic infrastructure to the federal government.
Quick answers
Who was awarded contract SPE2D626F867X?
SPE2D626F867X was awarded to Ortho-Clinical Diagnostics, Inc. by Medical Supply Chain (Troop Support) on December 5, 2025.
How much is contract SPE2D626F867X worth?
The government has obligated $2,716 on SPE2D626F867X.
Is contract SPE2D626F867X an order under another contract?
Yes. SPE2D626F867X is a delivery order under SPE2DE21D0007, an indefinite delivery contract.
Was contract SPE2D626F867X competed?
The extent of competition for SPE2D626F867X was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award